Chronic Care Platform Onduo by Verily focuses on virtual care for chronic conditions such as type 2 diabetes, hypertension, healthy weight, and pre-diabetes, presenting a direct opportunity to bundle digital therapeutics, remote monitoring, and personalized coaching into enterprise health programs.

Strategic Partnerships Recent activity shows Verily engaging with major players like Alphabet, Samsung, Salesforce, and UCHealth, suggesting a buyer preference for integrated precision health solutions; use these relationships to position bundled offerings with ecosystem compatibility for healthcare providers and employers.

Growth & Investment Verily secured substantial funding and expanded operations, including a $300M round and Singapore facility expansion, signaling scaleback readiness and potential for co-development, pilot programs, and regional deployment in Southeast Asia and beyond.

AI and DataAdvantage With a focus on precision health AI and partnerships around biomarker development and digital platforms like Verily Pre and Verily Me, there is an upsell path for enterprise clients seeking advanced analytics, patient engagement tools, and scalable data platforms.

Market Positioning Operating in the health tech and digital care space with competitors ranging from mySugr to Teladoc, Onduo can differentiate by offering integrated virtual care for chronic conditions married with hardware-compatible wearables and health data interoperability for health plans and employers.